367 related articles for article (PubMed ID: 32570802)
21. Exosomes in head and neck cancer: Roles, mechanisms and applications.
Cao J; Zhang M; Xie F; Lou J; Zhou X; Zhang L; Fang M; Zhou F
Cancer Lett; 2020 Dec; 494():7-16. PubMed ID: 32781015
[TBL] [Abstract][Full Text] [Related]
22. Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma.
Cao Y; Green K; Quattlebaum S; Milam B; Lu L; Gao D; He H; Li N; Gao L; Hall F; Whinery M; Handley E; Ma Y; Xu T; Jin F; Xiao J; Wei M; Smith D; Bornstein S; Gross N; Pyeon D; Song J; Lu SL
Clin Epigenetics; 2018; 10():43. PubMed ID: 29636832
[TBL] [Abstract][Full Text] [Related]
23. Proteomics-based Predictive Model for the Early Detection of Metastasis and Recurrence in Head and Neck Cancer.
Ribeiro IP; Esteves L; Anjo SI; Marques F; Barroso L; Manadas B; Carreira IM; Melo JB
Cancer Genomics Proteomics; 2020; 17(3):259-269. PubMed ID: 32345667
[TBL] [Abstract][Full Text] [Related]
24. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
Yang L; Kumar B; Shen C; Zhao S; Blakaj D; Li T; Romito M; Teknos TN; Williams TM
Mol Cancer Ther; 2019 Jun; 18(6):1025-1035. PubMed ID: 31015310
[TBL] [Abstract][Full Text] [Related]
25. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.
Tinhofer I; Staudte S
Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647
[TBL] [Abstract][Full Text] [Related]
26. Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma.
Payne K; Spruce R; Beggs A; Sharma N; Kong A; Martin T; Parmar S; Praveen P; Nankivell P; Mehanna H
Head Neck; 2018 Jul; 40(7):1598-1604. PubMed ID: 29542214
[TBL] [Abstract][Full Text] [Related]
27. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
[TBL] [Abstract][Full Text] [Related]
28. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM
BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339
[TBL] [Abstract][Full Text] [Related]
29. Transient Receptor Potential (TRP) Channels in Head-and-Neck Squamous Cell Carcinomas: Diagnostic, Prognostic, and Therapeutic Potentials.
Kiss F; Pohóczky K; Szállási A; Helyes Z
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887395
[TBL] [Abstract][Full Text] [Related]
30. The role of tumor DNA as a diagnostic tool for head and neck squamous cell carcinoma.
Chan JYK; Zhen G; Agrawal N
Semin Cancer Biol; 2019 Apr; 55():1-7. PubMed ID: 30082187
[TBL] [Abstract][Full Text] [Related]
31. The development of a liquid biopsy for head and neck cancers.
Schmidt H; Kulasinghe A; Kenny L; Punyadeera C
Oral Oncol; 2016 Oct; 61():8-11. PubMed ID: 27688098
[TBL] [Abstract][Full Text] [Related]
32. "TGM3 - A novel biomarker as a potential diagnostic target for head and neck squamous cell carcinoma (HNSCC)".
Muthukrishnan L
Oral Oncol; 2022 Nov; 134():106118. PubMed ID: 36096048
[No Abstract] [Full Text] [Related]
33. Transcriptome reprogramming by cancer exosomes: identification of novel molecular targets in matrix and immune modulation.
Qadir F; Aziz MA; Sari CP; Ma H; Dai H; Wang X; Raithatha D; Da Silva LGL; Hussain M; Poorkasreiy SP; Hutchison IL; Waseem A; Teh MT
Mol Cancer; 2018 Jul; 17(1):97. PubMed ID: 30008265
[TBL] [Abstract][Full Text] [Related]
34. Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review).
Frassanito MA; Saltarella I; Vinella A; Muzio LL; Pannone G; Fumarulo R; Vacca A; Mariggiò MA
Oncol Rep; 2019 May; 41(5):2615-2624. PubMed ID: 30896830
[TBL] [Abstract][Full Text] [Related]
35. The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer.
Hofmann L; Ludwig S; Schuler PJ; Hoffmann TK; Brunner C; Theodoraki MN
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466374
[TBL] [Abstract][Full Text] [Related]
36. Dual Sec62/Ki67 immunocytochemistry of liquid-based cytological preparations represents a highly valid biomarker for non-invasive detection of head and neck squamous cell carcinomas.
Kühn JP; Speicher S; Linxweiler B; Körner S; Rimbach H; Wagner M; Solomayer EF; Schick B; Linxweiler M
Cytopathology; 2024 Jan; 35(1):113-121. PubMed ID: 37787092
[TBL] [Abstract][Full Text] [Related]
37. Application of liquid biopsy as multi-functional biomarkers in head and neck cancer.
Mishra V; Singh A; Chen X; Rosenberg AJ; Pearson AT; Zhavoronkov A; Savage PA; Lingen MW; Agrawal N; Izumchenko E
Br J Cancer; 2022 Feb; 126(3):361-370. PubMed ID: 34876674
[TBL] [Abstract][Full Text] [Related]
38. Brain metastasis from squamous cell carcinoma of the head and neck: a review of the literature in the genomic era.
Barrett TF; Gill CM; Miles BA; Iloreta AMC; Bakst RL; Fowkes M; Brastianos PK; Bederson JB; Shrivastava RK
Neurosurg Focus; 2018 Jun; 44(6):E11. PubMed ID: 29852772
[TBL] [Abstract][Full Text] [Related]
39. The prognostic value of Tiam1 protein expression in head and neck squamous cell carcinoma: a retrospective study.
Yang H; Cai YC; Cao Y; Song M; An X; Xia Y; Wei J; Jiang WQ; Shi YX
Chin J Cancer; 2015 Sep; 34(12):614-21. PubMed ID: 26369827
[TBL] [Abstract][Full Text] [Related]
40. Breath biopsy, a novel technology to identify head and neck squamous cell carcinoma: A systematic review.
Kok R; van Schaijik B; Johnson NW; Malki MI; Frydrych A; Kujan O
Oral Dis; 2023 Nov; 29(8):3034-3048. PubMed ID: 35801385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
